Bladder cancer is a common cancer and one of the most costly to treat, yet there has been little change in the standard of care in 40 years. This panel will focus on the unmet needs in bladder ...

June 3, 2025 — Researchers have identified a gene that plays a key role in prostate cancer cells that have ... and Brain Stimulation Could Reduce Bladder Leaks May 30, 2025 — A new study ...

Add articles to your saved list and come back to them any time. A new treatment for bladder cancer is being rolled out across Australian hospitals, with doctors hopeful the approach will improve ...

With biomarker guidance after neoadjuvant chemotherapy, three-fourths of patients with muscle-invasive bladder cancer (MIBC) avoided cystectomy during 2 years of active surveillance, and almost ...

Also Read: UroGen Pharma Touts Four-Year Response With Urothelial Cancer Drug Study, Highlights Potential For Bladder Cancer Candidates Selvaraju notes that if UGN-102 does receive FDA approval ...

The recipient of the innovative procedure was Oscar Larrainzar, 41, a father of four who had a large portion of his bladder removed due to cancer several years ago, the University of California ...

As presented at the 2025 ASCO Annual Meeting: in a randomized controlled phase 3 trial evaluating subcutaneous administration of sasanlimab, an anti-PD-1 inhibitor, with Bacillus Calmette ...

This study looked at the possibility of doing a larger trial to compare different ways of treating high risk bladder cancer. High risk bladder cancer is more likely to: come back after treatment or ...

The first targeted drug for a common form of bladder cancer that can be taken at home has been backed for NHS use, offering hope of simpler treatment to hundreds of patients in England.